{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:25:01Z","timestamp":1790673901172,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Fellowship Award"],"award-info":[{"award-number":["Fellowship Award"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arseneau-Henry Families Research Fund"},{"name":"Joseph Doyle Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00520-017-3685-9","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T16:43:41Z","timestamp":1490978621000},"page":"2019-2033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5588-1007","authenticated-orcid":false,"given":"Kristopher","family":"Dennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Jamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Makhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Shun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"issue":"1","key":"3685_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.radonc.2009.11.001","volume":"94","author":"E Maranzano","year":"2010","unstructured":"Maranzano E, De Angelis V, Pergolizzi S, Lupattelli M, Frata P, Spagnesi S et al (2010) A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol 94(1):36\u201341","journal-title":"Radiother Oncol"},{"issue":"3","key":"3685_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0360-3016(99)00055-3","volume":"44","author":"The Italian Group for Antiemetic Research in Radiotherapy","year":"1999","unstructured":"The Italian Group for Antiemetic Research in Radiotherapy (1999) Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Biol Phys 44(3):619\u2013625","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"3685_CR3","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1007\/s00520-010-1036-1","volume":"19","author":"I Olver","year":"2011","unstructured":"Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G (2011) Antiemetic research: future directions. Support Care Cancer 19(Suppl 1):S49\u2013S55","journal-title":"Support Care Cancer"},{"issue":"6","key":"3685_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1586\/erp.11.77","volume":"11","author":"K Dennis","year":"2011","unstructured":"Dennis K, Maranzano E, De Angelis C, Holden L, Wong S, Chow E (2011) Radiotherapy-induced nausea and vomiting. Expert Rev Pharmacoecon Outcomes Res 11(6):685\u2013692","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"Suppl 1","key":"3685_CR5","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1007\/s00520-010-0950-6","volume":"19","author":"PC Feyer","year":"2011","unstructured":"Feyer PC, Maranzano E, Molassiotis A, Roila F, Clark-Snow RA, Jordan K (2011) Radiotherapy-induced nausea and vomiting (RINV): MASCC\/ESMO guideline for antiemetics in radiotherapy: update 2009. Support Care Cancer 19(Suppl 1):S5\u2013S14","journal-title":"Support Care Cancer"},{"issue":"31","key":"3685_CR6","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189\u20134198","journal-title":"J Clin Oncol"},{"issue":"1","key":"3685_CR7","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/j.ijrobp.2012.02.031","volume":"84","author":"K Dennis","year":"2012","unstructured":"Dennis K, Zhang L, Lutz S, van Baardwijk A, van der Linden Y, Holt T et al (2012) International patterns of practice in the management of radiation therapy-induced nausea and vomiting. Int J Radiat Oncol Biol Phys 84(1):e49\u2013e60","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"3685_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006\u20131012","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3685_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/clon.2001.0012","volume":"14","author":"JS Wu","year":"2002","unstructured":"Wu JS, Bezjak A, Chow E, Kirkbride P (2002) Primary treatment endpoint following palliative radiotherapy for painful bone metastases: need for a consensus definition? Clin Oncol (R Coll Radiol) 14(1):70\u201377","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"3685_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0009-9260(71)80130-7","volume":"22","author":"GH Berry","year":"1971","unstructured":"Berry GH, Duncan W, Bowman CM (1971) The prevention of radiation sickness. Report of a double blind random clinical trial using prochlorperazine and metopimazine. Clin Radiol 22(4):534\u2013537","journal-title":"Clin Radiol"},{"issue":"3","key":"3685_CR11","first-page":"82","volume":"96","author":"MK Mahajan","year":"1998","unstructured":"Mahajan MK, Singh V (1998) Assessment of efficacy of pyridoxine in control of radiation induced sickness. J Indian Med Assoc 96(3):82\u201383","journal-title":"J Indian Med Assoc"},{"issue":"3","key":"3685_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0090-3019(94)90272-0","volume":"42","author":"S Bodis","year":"1994","unstructured":"Bodis S, Alexander E 3rd, Kooy H, Loeffler JS (1994) The prevention of radiosurgery-induced nausea and vomiting by ondansetron: evidence of a direct effect on the central nervous system chemoreceptor trigger zone. Surg Neurol 42(3):249\u2013252","journal-title":"Surg Neurol"},{"issue":"4","key":"3685_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0360-3016(94)90356-5","volume":"30","author":"CW Scarantino","year":"1994","unstructured":"Scarantino CW, Ornitz RD, Hoffman LG, Anderson RF Jr (1994) On the mechanism of radiation-induced emesis: the role of serotonin. Int J Radiat Oncol Biol Phys 30(4):825\u2013830","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"3685_CR14","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2000.18.9.1960","volume":"18","author":"P Kirkbride","year":"2000","unstructured":"Kirkbride P, Bezjak A, Pater J, Zee B, Palmer MJ, Wong R et al (2000) Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol 18(9):1960\u20131966","journal-title":"J Clin Oncol"},{"issue":"21","key":"3685_CR15","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1200\/JCO.2005.04.4685","volume":"24","author":"RK Wong","year":"2006","unstructured":"Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A et al (2006) 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J Clin Oncol 24(21):3458\u20133464","journal-title":"J Clin Oncol"},{"issue":"2","key":"3685_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0167-8140(97)00099-6","volume":"45","author":"N Aass","year":"1997","unstructured":"Aass N, Hatun DE, Thoresen M, Fossa SD (1997) Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. Radiother Oncol 45(2):125\u2013128","journal-title":"Radiother Oncol"},{"issue":"3","key":"3685_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.bmt.1701565","volume":"23","author":"B Abbott","year":"1999","unstructured":"Abbott B, Ippoliti C, Bruton J, Neumann J, Whaley R, Champlin R (1999) Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation. Bone Marrow Transplant 23(3):265\u2013269","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3685_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0360-3016(96)00284-2","volume":"36","author":"Y Belkacemi","year":"1996","unstructured":"Belkacemi Y, Ozsahin M, Pene F, Rio B, Sutton L, Laporte JP et al (1996) Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis. Int J Radiat Oncol Biol Phys 36(1):77\u201382","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3685_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF01788845","volume":"4","author":"P Bey","year":"1996","unstructured":"Bey P, Wilkinson PM, Resbeut M, Bourdin S, Le Floch O, Hahne W et al (1996) A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer 4(5):378\u2013383","journal-title":"Support Care Cancer"},{"issue":"6","key":"3685_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/oxfordjournals.annonc.a010675","volume":"7","author":"L Franzen","year":"1996","unstructured":"Franzen L, Nyman J, Hagberg H, Jakobsson M, Sorbe B, Nyth AL et al (1996) A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 7(6):587\u2013592","journal-title":"Ann Oncol"},{"issue":"3","key":"3685_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0936-6555(96)80043-4","volume":"8","author":"SJ Gibbs","year":"1996","unstructured":"Gibbs SJ, Cassoni AM (1996) A pilot study to evaluate the cost-effectiveness of ondansetron and granisetron in fractionated total body irradiation. Clin Oncol (R Coll Radiol) 8(3):182\u2013184","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"3685_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3109\/02841869209083868","volume":"31","author":"R Henriksson","year":"1992","unstructured":"Henriksson R, Lomberg H, Israelsson G, Zackrisson B, Franzen L (1992) The effect of ondansetron on radiation-induced emesis and diarrhoea. Acta Oncol 31(7):767\u2013769","journal-title":"Acta Oncol"},{"issue":"4","key":"3685_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0936-6555(97)80011-8","volume":"9","author":"VS Khoo","year":"1997","unstructured":"Khoo VS, Rainford K, Horwich A, Dearnaley DP (1997) The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study. Clin Oncol (R Coll Radiol) 9(4):252\u2013257","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"3685_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1081\/CNV-100107736","volume":"19","author":"R Lanciano","year":"2001","unstructured":"Lanciano R, Sherman DM, Michalski J, Preston AJ, Yocom K, Friedman C (2001) The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Investig 19(8):763\u2013772","journal-title":"Cancer Investig"},{"issue":"5","key":"3685_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0936-6555(05)80871-4","volume":"3","author":"JP Logue","year":"1991","unstructured":"Logue JP, Magee B, Hunter RD, Murdoch RD (1991) The antiemetic effect of granisetron in lower hemibody radiotherapy. Clin Oncol (R Coll Radiol) 3(5):247\u2013249","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3B","key":"3685_CR26","first-page":"2011","volume":"18","author":"R Maisano","year":"1998","unstructured":"Maisano R, Pergolizzi S, Settineri N (1998) Escalating dose of oral ondansetron in the prevention of radiation induced emesis. Anticancer Res 18(3B):2011\u20132013","journal-title":"Anticancer Res"},{"issue":"5C","key":"3685_CR27","first-page":"3631","volume":"20","author":"M Morita","year":"2000","unstructured":"Morita M, Kuwano H, Ohno S, Kitamura K, Sugimachi K (2000) Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer. Anticancer Res 20(5C):3631\u20133636","journal-title":"Anticancer Res"},{"issue":"1","key":"3685_CR28","first-page":"29","volume":"15","author":"K Mystakidou","year":"2010","unstructured":"Mystakidou K, Kouloulias V, Nikolaou V, Tsilika E, Lymperopoulou G, Balafouta M et al (2010) A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy. J BUON 15(1):29\u201335","journal-title":"J BUON"},{"issue":"5","key":"3685_CR29","first-page":"679","volume":"17","author":"S Okamoto","year":"1996","unstructured":"Okamoto S, Takahashi S, Tanosaki R, Sakamaki H, Onozawa Y, Oh H et al (1996) Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Bone Marrow Transplant 17(5):679\u2013683","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3685_CR30","first-page":"445","volume":"15","author":"HG Prentice","year":"1995","unstructured":"Prentice HG, Cunningham S, Gandhi L, Cunningham J, Collis C, Hamon MD (1995) Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 15(3):445\u2013448","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3685_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0936-6555(05)80790-3","volume":"2","author":"TJ Priestman","year":"1990","unstructured":"Priestman TJ, Roberts JT, Lucraft H, Collis CH, Adams M, Upadhyaya BK et al (1990) Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol (R Coll Radiol) 2(2):71\u201375","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"3685_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0936-6555(05)80086-X","volume":"5","author":"TJ Priestman","year":"1993","unstructured":"Priestman TJ, Roberts JT, Upadhyaya BK (1993) A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol (R Coll Radiol) 5(6):358\u2013363","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"Suppl 3","key":"3685_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00003495-199200433-00008","volume":"43","author":"B Sorbe","year":"1992","unstructured":"Sorbe B, Berglind AM (1992) Tropisetron, a new 5-HT3-receptor antagonist, in the prevention of radiation-induced nausea, vomiting and diarrhoea. Drugs 43(Suppl 3):33\u201339","journal-title":"Drugs"},{"issue":"11","key":"3685_CR34","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1200\/JCO.1994.12.11.2432","volume":"12","author":"TR Spitzer","year":"1994","unstructured":"Spitzer TR, Bryson JC, Cirenza E, Foelber R, Wallerstadt M, Stout C et al (1994) Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 12(11):2432\u20132438","journal-title":"J Clin Oncol"},{"issue":"2","key":"3685_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.bmt.1702479","volume":"26","author":"TR Spitzer","year":"2000","unstructured":"Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J (2000) Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Bone Marrow Transplant 26(2):203\u2013210","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"3685_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s005200050119","volume":"5","author":"AJ Sykes","year":"1997","unstructured":"Sykes AJ, Kiltie AE, Stewart AL (1997) Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. Support Care Cancer 5(6):500\u2013503","journal-title":"Support Care Cancer"},{"issue":"4","key":"3685_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/10428199209049784","volume":"7","author":"C Tiley","year":"1992","unstructured":"Tiley C, Powles R, Catalano J, Treleaven J, Eshelby J, Hewetson M et al (1992) Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation. Leuk Lymphoma 7(4):317\u2013321","journal-title":"Leuk Lymphoma"},{"issue":"5559","key":"3685_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bmj.3.5559.215","volume":"3","author":"H Mattie","year":"1967","unstructured":"Mattie H, Emery EW, Hill ID, Laurence DR (1967) Treatment of radiation sickness with pyridoxine hydrochloride in outpatients of a radiotherapy unit. Br Med J (Clin Res Ed) 3(5559):215\u2013216","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"3685_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0009-9260(68)80072-8","volume":"19","author":"K Sicher","year":"1968","unstructured":"Sicher K, Backhouse TW (1968) An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting. Clin Radiol 19(2):238\u2013240","journal-title":"Clin Radiol"},{"issue":"9","key":"3685_CR40","first-page":"1558","volume":"74","author":"DR Cole","year":"1974","unstructured":"Cole DR, Duffy DF (1974) Haloperidol for radiation sickness: control of associated nausea, vomiting, and anorexia. N Y State J Med 74(9):1558\u20131562","journal-title":"N Y State J Med"},{"issue":"7942","key":"3685_CR41","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(75)90358-X","volume":"2","author":"AT Mennie","year":"1975","unstructured":"Mennie AT, Dalley VM, Dinneen LC, Collier HO (1975) Treatment of radiation-induced gastrointestinal distress with acetylsalicylate. Lancet 2(7942):942\u2013943","journal-title":"Lancet"},{"issue":"10","key":"3685_CR42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1742-1241.1976.tb05150.x","volume":"30","author":"G Rowlands","year":"1976","unstructured":"Rowlands G, Currie WJ (1976) A trial of valoid (cyclizine) tablets in the control of the nausea and vomiting associated with radiation therapy. Br J Clin Pract 30(10):197\u2013199","journal-title":"Br J Clin Pract"},{"issue":"11\u201312","key":"3685_CR43","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/0360-3016(79)90958-1","volume":"5","author":"JA Stryker","year":"1979","unstructured":"Stryker JA, Demers LM, Mortel R (1979) Prophylactic ibuprofen administration during pelvic irradiation. Int J Radiat Oncol Biol Phys 5(11\u201312):2049\u20132052","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3685_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00002820-198010000-00003","volume":"3","author":"DA Welch","year":"1980","unstructured":"Welch DA (1980) Assessment of nausea and vomiting in cancer patients undergoing external beam radiotherapy. Cancer Nurs 3(5):365\u2013371","journal-title":"Cancer Nurs"},{"issue":"4","key":"3685_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jama.1981.03310290055028","volume":"245","author":"S Frytak","year":"1981","unstructured":"Frytak S, Moertel CG (1981) Management of nausea and vomiting in the cancer patient. JAMA 245(4):393\u2013396","journal-title":"JAMA"},{"issue":"6","key":"3685_CR46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0009-9260(82)80383-8","volume":"33","author":"HH Lucraft","year":"1982","unstructured":"Lucraft HH, Palmer MK (1982) Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting. Clin Radiol 33(6):621\u2013622","journal-title":"Clin Radiol"},{"issue":"39","key":"3685_CR47","first-page":"1792","volume":"101","author":"V Budach","year":"1983","unstructured":"Budach V (1983) Antiemetic efficacy of alizapride\/metoclopramide in cancer radiotherapy-induced nausea and vomiting. Fortschr Med 101(39):1792\u20131794","journal-title":"Fortschr Med"},{"issue":"2","key":"3685_CR48","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1148\/radiology.150.2.6318262","volume":"150","author":"JT Ungerleider","year":"1984","unstructured":"Ungerleider JT, Andrysiak TA, Fairbanks LA, Tesler AS, Parker RG (1984) Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy. Radiology 150(2):598\u2013599","journal-title":"Radiology"},{"issue":"5","key":"3685_CR49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0009-9260(87)80151-4","volume":"38","author":"SG Priestman","year":"1987","unstructured":"Priestman SG, Priestman TJ, Canney PA (1987) A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea. Clin Radiol 38(5):543\u2013544","journal-title":"Clin Radiol"},{"issue":"1","key":"3685_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF01613203","volume":"117","author":"K Bremer","year":"1991","unstructured":"Bremer K (1991) 5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis. J Cancer Res Clin Oncol 117(1):85\u201387","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3685_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0936-6555(05)80785-X","volume":"4","author":"JT Roberts","year":"1992","unstructured":"Roberts JT (1992) Ondansetron in the control of refractory emesis following radiotherapy. Clin Oncol (R Coll Radiol) 4(1):67\u201368","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8791","key":"3685_CR52","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/0140-6736(92)91095-P","volume":"339","author":"SA Rosenthal","year":"1992","unstructured":"Rosenthal SA, Marquez CM, Hourigan HP, Ryu JK (1992) Ondansetron for patients given abdominal radiotherapy. Lancet 339(8791):490","journal-title":"Lancet"},{"issue":"2","key":"3685_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0167-8140(92)90345-U","volume":"23","author":"B Sorbe","year":"1992","unstructured":"Sorbe B, Berglind AM, de Bruijn K (1992) Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesis. Radiother Oncol 23(2):131\u2013132","journal-title":"Radiother Oncol"},{"issue":"5","key":"3685_CR54","first-page":"382","volume":"13","author":"B Sorbe","year":"1992","unstructured":"Sorbe B, Berglind AM, De Bruijn K (1992) Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of irradiation-induced nausea, vomiting and diarrhoea. Eur J Gynaecol Oncol 13(5):382\u2013389","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"3685_CR55","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/clon.1999.9077","volume":"11","author":"JP LeBourgeois","year":"1999","unstructured":"LeBourgeois JP, McKenna CJ, Coster B, Feyer P, Franzen L, Goedhals L et al (1999) Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Clin Oncol (R Coll Radiol) 11(5):340\u2013347","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"3685_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jjco\/hyn140","volume":"39","author":"K Kim","year":"2009","unstructured":"Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA et al (2009) Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer. Jpn J Clin Oncol 39(2):111\u2013115","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"3685_CR57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20034","volume":"59","author":"MD Pinkowish","year":"2009","unstructured":"Pinkowish MD (2009) Acupressure and acupuncture for side effects of radiotherapy. CA Cancer J Clin 59(5):277\u2013280","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3685_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jpainsymman.2008.09.006","volume":"38","author":"JA Roscoe","year":"2009","unstructured":"Roscoe JA, Bushunow P, Jean-Pierre P, Heckler CE, Purnell JQ, Peppone LJ et al (2009) Acupressure bands are effective in reducing radiation therapy-related nausea. J Pain Symptom Manag 38(3):381\u2013389","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"3685_CR59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7257\/1053-816X.2010.30.3.195","volume":"30","author":"S Keats","year":"2010","unstructured":"Keats S (2010) High-dose rate brachytherapy in prostate cancer patients\u2014a study on nausea and vomiting. Urol Nurs 30(3):195\u2013202","journal-title":"Urol Nurs"},{"issue":"3","key":"3685_CR60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12032-009-9307-8","volume":"27","author":"GH Li","year":"2010","unstructured":"Li GH, Wang DL, Hu YD, Pu P, Li DZ, Wang WD et al (2010) Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol 27(3):919\u2013925","journal-title":"Med Oncol"},{"issue":"1","key":"3685_CR61","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.mehy.2009.07.017","volume":"74","author":"C Liu","year":"2010","unstructured":"Liu C, Cui J, Sun Q, Cai J (2010) Hydrogen therapy may be an effective and specific novel treatment for acute radiation syndrome. Med Hypotheses 74(1):145\u2013146","journal-title":"Med Hypotheses"},{"issue":"3","key":"3685_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014766","volume":"6","author":"A Enblom","year":"2011","unstructured":"Enblom A, Lekander M, Hammar M, Johnsson A, Onelov E, Ingvar M et al (2011) Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care. PLoS One 6(3):e14766","journal-title":"PLoS One"},{"key":"3685_CR63","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/annonc\/mdr402","volume":"23","author":"A Enblom","year":"2012","unstructured":"Enblom A, Johnsson A, Hammar M, Onelov E, Steineck G, Borjeson S (2012) Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea\u2014a randomized controlled study. Annals Oncol 23:1353\u20131361","journal-title":"Annals Oncol"},{"issue":"4","key":"3685_CR64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/1735-1995.158244","volume":"20","author":"H Emami","year":"2015","unstructured":"Emami H, Hematti S, Saeidian SM, Feizi A, Taheri S, Pourya A et al (2015) The efficacy of combination of andansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting. J Res Med Sci 20(4):329\u2013333","journal-title":"J Res Med Sci"},{"issue":"4814","key":"3685_CR65","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/bmj.1.4814.802","volume":"1","author":"WM Brown","year":"1953","unstructured":"Brown WM (1953) Symptomatic disturbance after single therapeutic dose of x rays; its relationship to the general radiation syndrome. Br Med J (Clin Res Ed) 1(4814):802\u2013805","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"3685_CR66","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/cpt1969106800","volume":"10","author":"FC Chu","year":"1969","unstructured":"Chu FC, Paulshock M, Wallenstein SL, Houde RW, Phillips R (1969) A controlled clinical study of metopimazine and perphenazine in treatment of radiation nausea and vomiting. Clin Pharmacol Ther 10(6):800\u2013809","journal-title":"Clin Pharmacol Ther"},{"key":"3685_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/00016926109176647","volume":"56","author":"JA Parsons","year":"1961","unstructured":"Parsons JA, Webster JH, Dowd JE (1961) Evaluation of the placebo effect in the treatment of radiation sickness. Acta Radiol 56:129\u2013140","journal-title":"Acta Radiol"},{"issue":"3","key":"3685_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0368-2242(52)80009-0","volume":"3","author":"F Ellis","year":"1952","unstructured":"Ellis F, Stoll BA (1952) Radiation sickness: a clinical investigation. J Fac Radiol 3(3):207\u2013222","journal-title":"J Fac Radiol"},{"issue":"3","key":"3685_CR69","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1148\/68.3.380","volume":"68","author":"BA Stoll","year":"1957","unstructured":"Stoll BA (1957) New drugs for irradiation sickness. Radiology 68(3):380\u2013385","journal-title":"Radiology"},{"issue":"5159","key":"3685_CR70","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/bmj.2.5159.1068","volume":"2","author":"MJ Solan","year":"1959","unstructured":"Solan MJ (1959) Prochlorperazine and irradiation sickness. Br Med J (Clin Res Ed) 2(5159):1068\u20131069","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3685_CR71","first-page":"404","volume":"7","author":"I Kuzma","year":"1960","unstructured":"Kuzma I, Siracka-Vesela E (1960) The application of the antikinetic therapeutic agent \u201cmarzine\u201d in the treatment of the radiation sickness. Neoplasma 7:404\u2013407","journal-title":"Neoplasma"},{"key":"3685_CR72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0009-9260(61)80015-9","volume":"12","author":"R Finney","year":"1961","unstructured":"Finney R (1961) \u201cNidoxital\u201d: a clinical trial. Clin Radiol 12:229\u2013231","journal-title":"Clin Radiol"},{"key":"3685_CR73","first-page":"375","volume":"174","author":"VA Codiga","year":"1961","unstructured":"Codiga VA (1961) A new antiemetic for the treatment of nausea and vomiting associated with roentgen therapy. Int Rec Med 174:375\u2013379","journal-title":"Int Rec Med"},{"key":"3685_CR74","first-page":"178","volume":"4","author":"J Cox","year":"1962","unstructured":"Cox J, Collins JH (1962) Nausea and vomiting: control by thiethylperazine. Curr Ther Res Clin Exp 4:178\u2013181","journal-title":"Curr Ther Res Clin Exp"},{"key":"3685_CR75","first-page":"237","volume":"26","author":"W Jasinski","year":"1962","unstructured":"Jasinski W, Swiecki J, Gajl D (1962) Treatment of radiation sickness with marzine (cyclizine HCl). Pol Przegl Radiol 26:237\u2013239","journal-title":"Pol Przegl Radiol"},{"key":"3685_CR76","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5694\/j.1326-5377.1963.tb25569.x","volume":"1","author":"J Donovan","year":"1963","unstructured":"Donovan J (1963) Radiation sickness and its control with thiethylperazine (\u201ctorecan\u201d): a preliminary evaluation. Med J Aust 1:614\u2013615","journal-title":"Med J Aust"},{"key":"3685_CR77","first-page":"222","volume":"21","author":"K Fochem","year":"1964","unstructured":"Fochem K (1964) On the treatment of radiation syndromes with cyclizine (marezine). Ther Umsch 21:222\u2013224","journal-title":"Ther Umsch"},{"issue":"7","key":"3685_CR78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5694\/j.1326-5377.1965.tb25242.x","volume":"2","author":"JA Holt","year":"1965","unstructured":"Holt JA (1965) A trial of thiethylperazine (\u201ctorecan\u201d) in patients suffering from radiation sickness. Med J Aust 2(7):279\u2013281","journal-title":"Med J Aust"},{"issue":"399","key":"3685_CR79","first-page":"649","volume":"64","author":"EM Johnson","year":"1965","unstructured":"Johnson EM (1965) The control of radiation sickness with thiethylperazine (torecan). N Z Med J 64(399):649\u2013650","journal-title":"N Z Med J"},{"issue":"2","key":"3685_CR80","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1148\/86.2.262","volume":"86","author":"SS Kurohara","year":"1966","unstructured":"Kurohara SS, George FW 3rd, Levitts S, Rubin P (1966) Factor concerned with \u201cclinical radiation nausea\u201d. Radiology 86(2):262\u2013265","journal-title":"Radiology"},{"issue":"6","key":"3685_CR81","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1213\/00000539-197211000-00034","volume":"51","author":"FJ Tornetta","year":"1972","unstructured":"Tornetta FJ (1972) Double-blind evaluation of haloperidol for antiemetic activity. Anesth Analg 51(6):964\u2013967","journal-title":"Anesth Analg"},{"issue":"2","key":"3685_CR82","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/bjc.1987.177","volume":"56","author":"WD Miner","year":"1987","unstructured":"Miner WD, Sanger GJ, Turner DH (1987) Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis. Br J Cancer 56(2):159\u2013162","journal-title":"Br J Cancer"},{"key":"3685_CR83","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0936-6555(05)80752-6","volume":"3","author":"CH Collis","year":"1991","unstructured":"Collis CH, Priestman TJ, Priestman S, Lucraft H, Roberts JT, Adams M et al (1991) The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol (R Coll Radiol) 3:241\u2013242","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"3685_CR84","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000227174","volume":"50","author":"M Clavel","year":"1993","unstructured":"Clavel M, Soukop M, Greenstreet YL (1993) Improved control of emesis and quality of life with ondansetron in breast cancer. Oncology (Williston Park) 50(3):180\u2013185","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"3685_CR85","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/0959-8049(95)00208-Z","volume":"31A","author":"R Miralbell","year":"1995","unstructured":"Miralbell R, Coucke P, Behrouz F, Blazek N, Melliger M, Philipp S et al (1995) Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. Eur J Cancer 31A(9):1461\u20131464","journal-title":"Eur J Cancer"},{"issue":"6","key":"3685_CR86","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","volume":"29","author":"DM Savarese","year":"2003","unstructured":"Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B (2003) Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29(6):501\u2013513","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"3685_CR87","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1148\/66.3.403","volume":"66","author":"A Silverman","year":"1956","unstructured":"Silverman A, Kligerman MM, Fertig JW, Ellis K (1956) A study of the effectiveness of pyridoxine and dramamine on clinical radiation sickness. Radiology 66(3):403\u2013407","journal-title":"Radiology"},{"issue":"2","key":"3685_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0368-2242(58)80018-4","volume":"9","author":"R Finney","year":"1958","unstructured":"Finney R (1958) Cortisone and the treatment of radiation sickness. J Fac Radiol 9(2):68\u201379","journal-title":"J Fac Radiol"},{"key":"3685_CR89","first-page":"752","volume":"86","author":"JA Burwell","year":"1961","unstructured":"Burwell JA, Wolfson B, Perryman CR, Foldes FF (1961) The use of trimethobenzamide (tigan) for the treatment of radiation induced nausea and emesis. Am J Roentgenol Radium Therapy, Nucl Med 86:752\u2013756","journal-title":"Am J Roentgenol Radium Therapy, Nucl Med"},{"issue":"4","key":"3685_CR90","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF00874423","volume":"11","author":"M Aapro","year":"1993","unstructured":"Aapro M (1993) Methodological issues in antiemetic studies. Investig New Drugs 11(4):243\u2013253","journal-title":"Investig New Drugs"},{"issue":"3","key":"3685_CR91","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s005200050157","volume":"6","author":"PJ Hesketh","year":"1998","unstructured":"Hesketh PJ, Gralla RJ, du Bois A, Tonato M (1998) Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer 6(3):221\u2013227","journal-title":"Support Care Cancer"},{"issue":"10 Suppl","key":"3685_CR92","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/cncr.1984.53.s10.2267","volume":"53","author":"GR Morrow","year":"1984","unstructured":"Morrow GR (1984) Methodology in behavioral and psychosocial cancer research. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research. Cancer 53(10 Suppl):2267\u20132280","journal-title":"Cancer"},{"issue":"5","key":"3685_CR93","first-page":"555","volume":"70","author":"IN Olver","year":"1986","unstructured":"Olver IN, Simon RM, Aisner J (1986) Antiemetic studies: a methodological discussion. Cancer Treat Rep 70(5):555\u2013563","journal-title":"Cancer Treat Rep"},{"issue":"Suppl 1","key":"3685_CR94","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000227648","volume":"53","author":"IN Olver","year":"1996","unstructured":"Olver IN (1996) Antiemetic study methodology: recommendations for future studies. Oncology (Williston Park) 53(Suppl 1):96\u2013101","journal-title":"Oncology (Williston Park)"},{"issue":"4","key":"3685_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF01358880","volume":"4","author":"M Tonato","year":"1996","unstructured":"Tonato M, Roila F, Del Favero A, Ballatori E (1996) Methodology of trials with antiemetics. Support Care Cancer 4(4):281\u2013286","journal-title":"Support Care Cancer"},{"key":"3685_CR96","unstructured":"Multinational Association of Supportive Care in Cancer. MASCC Antiemesis Tool (MAT). Accessed October 4 2016. www.mascc.org\/mat ."},{"issue":"2","key":"3685_CR97","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00265968","volume":"38","author":"A Del Favero","year":"1990","unstructured":"Del Favero A, Roila F, Basurto C, Minotti V, Ballatori E, Patoia L et al (1990) Assessment of nausea. Eur J Clin Pharmacol 38(2):115\u2013120","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3685_CR98","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13566-012-0030-2","volume":"2","author":"K Dennis","year":"2013","unstructured":"Dennis K, Makhani L, Maranzano E, Feyer P, Zeng L, De Angelis C et al (2013) Timing and duration of 5-HT3 receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies. J Radiat Oncol 2(3):271\u2013284","journal-title":"J Radiat Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3685-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3685-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3685-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T23:27:13Z","timestamp":1692746833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3685-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3685-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}